ADAMTS13 Plays a Novel Role in Hyperfibrinolysis After Trauma-Induced Shock
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, reposted from Derek Kleinveld on LinkedIn:
”Thank you Derek Kleinveld for the opportunity to collaborate with my group.”
Quoting Derek Kleinveld‘s post:
”Happy to share our latest publication on a novel role for ADAMTS13 in trauma-induced shock. Thanks to all collaborators!”
Title: A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock
Authors: Pieter H. Sloos, Lisa Vermeersch, Daphne S. Roozendaal, Anne-Sophie Delmote, Cornelis van ‘t Veer, Thomas O. Momanyi, Frida Z. Miranda, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld
Read the full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Mar 16, 2026, 07:26James Crowley, Professor of Medicine emeritus at Brown University, posted on LinkedIn:
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency